Analyst Ratings For Aurinia Pharmaceuticals (NASDAQ:AUPH)
Today, Royal Bank of Canada initiated coverage on Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Outperform with a price target of $9.00.
Some recent analyst ratings include
- 2/8/2018-Royal Bank of Canada initiated coverage with a Outperform rating.
- 11/15/2017-HC Wainwright Reiterated Rating of Buy.
- 10/23/2017-Cantor Fitzgerald Reiterated Rating of Buy.
- 10/6/2017-Seaport Global Securities Reiterated Rating of Buy.
- 4/11/2017-FBR & Co Reiterated Rating of Outperform.
Recent Trading Activity for Aurinia Pharmaceuticals (NASDAQ:AUPH)
Shares of Aurinia Pharmaceuticals closed the previous trading session at 5.40 up +0.23 4.45% with 5.269999980926514 shares trading hands.